返回
RemeGen Co., Ltd.（09995.HK）价格
09995.HK 股价走势图
REMEGEN (09995.HK)
RemeGen Co., Ltd.
HK$93.7
-1.67%
$-1.59
盘中： Jan 20, 15:27:40 HKT
暂无数据Follow-Up Questions
RemeGen Co., Ltd. 的关键财务报表是什么？
09995.HK 的关键财务比率是什么？
RemeGen Co., Ltd. 的收入按细分市场或地理位置如何划分？
RemeGen Co., Ltd. 是否盈利？
RemeGen Co., Ltd. 有负债吗？
RemeGen Co., Ltd. 的流通股有多少？
关键数据
前收盘价
$95.2
开盘价
$95.3
当日区间
$92 - $95.8
52周范围
$11.52 - $126.6
交易量
4.4M
平均成交量
5.2M
每股收益（TTM）
-2.35
股息收益率
--
市值
$19.5B
什么是 REMEGEN？
RemeGen Co Ltd is a CN-based company operating in Biotechnology industry. The company is headquartered in Yantai, Shandong and currently employs 2,999 full-time employees. The company went IPO on 2020-11-09. RemeGen Co Ltd is a China-based company principally engaged in biopharmaceutical research, biopharmaceutical service, biopharmaceutical production and sale. The firm focuses on therapeutic antibody drugs such as antibody-drug conjugates (ADC), antibody fusion proteins, monoclonal antibodies and bispecific antibodies. The Company’s main products include telitacicept, disitamab vedotin, RC28-E and others. The firm's products are mainly used to treat major diseases such as autoimmune diseases, oncology and ophthalmology. The firm mainly operates its businesses in the domestic and overseas markets.